KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Common Equity: 2009-2025

Historic Common Equity for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $3.4 billion.

  • Charles River Laboratories International's Common Equity fell 9.95% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 9.95%. This contributed to the annual value of $3.5 billion for FY2024, which is 3.76% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Common Equity of $3.4 billion as of Q3 2025, which was up 1.51% from $3.4 billion recorded in Q2 2025.
  • Charles River Laboratories International's Common Equity's 5-year high stood at $3.8 billion during Q3 2024, with a 5-year trough of $2.2 billion in Q1 2021.
  • Over the past 3 years, Charles River Laboratories International's median Common Equity value was $3.4 billion (recorded in 2025), while the average stood at $3.4 billion.
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 32.25% in 2021, then declined by 12.23% in 2025.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Common Equity stood at $2.5 billion in 2021, then rose by 17.41% to $3.0 billion in 2022, then rose by 20.84% to $3.6 billion in 2023, then dropped by 3.76% to $3.5 billion in 2024, then declined by 9.95% to $3.4 billion in 2025.
  • Its last three reported values are $3.4 billion in Q3 2025, $3.4 billion for Q2 2025, and $3.2 billion during Q1 2025.